Sanara MedTech's balance sheet is strained due to liabilitie...

Sanara MedTech's balance sheet is strained due to liabilities and lack of profitability. Its use of debt is risky, given its negative EBIT and free cash flow. However, its top-line growth is viewed positively.

Is Sanara MedTech (NASDAQ:SMTI) Using Too Much Debt?

Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more

Translate

Report

1500 Views

Comment

Moomoo AI

Moomoo AI Official Account

Your AI assistant for discovering investment opportunities.

4560Followers

0Following

9967Visitors